NanoViricides Inc. (NNVC)

[BonelessCat]

Hard to say. That would come out of FDA guidance. But, there is no delay due to load times during phases. There would be no waiting for data in phase 2 and 3 trials.

Under orphan drug and accelerated program:
6 months to 1 year for phase 1
I season phase 2
1 season phase 3
Approval 6 months following NDA with a high priority review

In the meantime, ministries of health in regions hard hit by dengue would have the ability to approve use first as compassionate use and then as a treatment after the tox package is done.